埃克力西斯公司
DE ˙ DB ˙ US30161Q1040
€43.88 ↑2.53 (6.13%)
2026-06-04
分享價格
SecurityDE:EX9 / Exelixis, Inc.
InstitutionMackenzie Financial Corp
Latest Disclosed Ownership70,427 shares
Latest Disclosed Value $ 3,020,614
Mackenzie Financial Corp reports 61.22% increase in ownership of EX9 / Exelixis, Inc.

On May 13, 2026 - Mackenzie Financial Corp filed a 13F-HR form disclosing ownership of 70,427 shares of Exelixis, Inc. (DE:EX9) valued at $2,619,884 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 43,685 shares of Exelixis, Inc.. This represents a change in shares of 61.22% during the quarter. The current value of the position is $3,089,985 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EXELIXIS COM 30161Q104 70,427 26,742 61.22 3,021 57.29 0.0036
2026-02-18 2025-12-31 13F EXELIXIS COM 30161Q104 43,685 5,290 13.78 1,920 21.14 0.0023
2025-11-13 2025-09-30 13F EXELIXIS COM 30161Q104 38,395 -60,913 -61.34 1,586 -63.79 0.0019
2025-08-13 2025-06-30 13F EXELIXIS COM 30161Q104 99,308 -166,802 -62.68 4,377 -55.45 0.0057
2025-05-07 2025-03-31 13F EXELIXIS COM 30161Q104 266,110 -61,906 -18.87 9,825 -10.05 0.0140
2025-05-02 2024-12-31 13F/A-2 EXELIXIS COM 30161Q104 328,016 -75,522 -18.71 10,923 4.31 0.0149
2025-02-20 2024-12-31 13F/A-1 EXELIXIS COM 30161Q104 328,016 -75,522 10,923 0.0142
2025-02-14 2024-12-31 13F Exelixis Common Stock 30161Q104 328,016 -75,522 11,034 0.0158
2024-11-13 2024-09-30 13F EXELIXIS COM 30161Q104 403,538 -29,773 -6.87 10,472 7.55 0.0146
2024-08-14 2024-06-30 13F EXELIXIS COM 30161Q104 433,311 166,057 62.13 9,736 53.54 0.0145
2024-05-10 2024-03-31 13F EXELIXIS COM 30161Q104 267,254 42,845 19.09 6,342 17.80 0.0091
2024-01-30 2023-12-31 13F EXELIXIS COM 30161Q104 224,409 7,823 3.61 5,384 13.61 0.0081
2023-10-25 2023-09-30 13F EXELIXIS COM 30161Q104 216,586 25,293 13.22 4,739 29.49 0.0080
2023-08-03 2023-06-30 13F EXELIXIS COM 30161Q104 191,293 191,293 3,659 0.0056
2023-04-24 2023-03-31 13F EXELIXIS COM 30161Q104 0 -26,861 -100.00 0 -100.00
2023-02-14 2022-12-31 13F EXELIXIS COM 30161Q104 26,861 5,036 23.07 431 25.73 0.0007
2022-10-07 2022-09-30 13F Exelixis Common Stock 30161Q104 21,825 21,825 342 0.0006
2022-05-13 2022-03-31 13F EXELIXIS COM 30161Q104 0 -86,408 -100.00 0 -100.00
2022-02-14 2021-12-31 13F EXELIXIS COM 30161Q104 86,408 -83,200 -49.05 1,580 -55.94 0.0021
2021-11-08 2021-09-30 13F EXELIXIS COM 30161Q104 169,608 -71,715 -29.72 3,586 -18.44 0.0051
2021-08-11 2021-06-30 13F EXELIXIS COM 30161Q104 241,323 40,915 20.42 4,397 -2.87 0.0061
2021-05-14 2021-03-31 13F EXELIXIS COM 30161Q104 200,408 200,408 4,527 0.0069
2021-02-10 2020-12-31 13F EXELIXIS COM 30161Q104 0 -10,588 -100.00 0 -100.00
2020-11-13 2020-09-30 13F EXELIXIS COM 30161Q104 10,588 -4,168 -28.25 259 -26.00 0.0006
2020-08-13 2020-06-30 13F EXELIXIS COM 30161Q104 14,756 -151,728 -91.14 350 -87.79 0.0009
2020-05-14 2020-03-31 13F EXELIXIS COM 30161Q104 166,484 -218,897 -56.80 2,867 -57.78 0.0092
2020-02-13 2019-12-31 13F EXELIXIS COM 30161Q104 385,381 374,480 3,435.28 6,790 3,418.13 0.0167
2019-11-14 2019-09-30 13F EXELIXIS COM 30161Q104 10,901 -19,464 -64.10 193 -70.26 0.0005
2019-08-23 2019-06-30 13F/A-1 EXELIXIS COM 30161Q104 30,365 -19,900 -39.59 649 -45.74 0.0017
2019-08-14 2019-06-30 13F EXELIXIS COM 30161Q104 30,365 -19,900 649
2019-05-15 2019-03-31 13F EXELIXIS COM 30161Q104 50,265 6,196 14.06 1,196 37.95 0.0029
2019-02-06 2018-12-31 13F EXELIXIS COM 30161Q104 44,069 2,795 6.77 867 18.60 0.0023
2018-11-15 2018-09-30 13F EXELIXIS COM 30161Q104 41,274 12,876 45.34 731 19.64 0.0018
2018-08-13 2018-06-30 13F EXELIXIS COM 30161Q104 28,398 5,867 26.04 611 22.44 0.0016
2018-05-14 2018-03-31 13F/A-1 EXELIXIS COM 30161Q104 22,531 6,461 40.21 499 2.04 0.0013
2018-05-14 2018-03-31 13F EXELIXIS COM 30161Q104 22,531 499
2018-02-13 2017-12-31 13F EXELIXIS COM 30161Q104 16,070 5,954 58.86 489 99.59 0.0012
2017-11-13 2017-09-30 13F EXELIXIS COM 30161Q104 10,116 1,963 24.08 245 21.89 0.0013
2017-08-14 2017-06-30 13F EXELIXIS COM 30161Q104 8,153 8,153 201 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.